Landiolol Does Not Enhance the Effect of Ischemic Preconditioning in Isolated Rat Hearts

Overview

Journal J Anesth

Specialty Anesthesiology

Date 2010 Jan 20

PMID 20084408

Authors

Shuchun Yu

Takasumi Katoh

Hisako Okada

Hiroshi Makino

Soichiro Mimuro

Shigehito Sato

Affiliations

Soon will be listed here.

Abstract

Purpose: To determine the effect of landiolol on ischemic preconditioned rat hearts.

Methods: Isolated perfused rat hearts were divided into 8 groups. In the control group, there was no treatment before the 30-min global ischemia. In the landiolol infused groups, landiolol (100, 300, and 500 microM) was infused without ischemic preconditioning (IPC). In other groups, hearts were pretreated with 2 episodes of 5-min global ischemia and reperfusion before the 30-min ischemia. During the preconditioning, landiolol (0, 100, 300, and 500 microM) was infused.

Results: Recoveries of coronary flow (CF) and myocardial oxygen consumption (MVO(2)) at the 120th min after global ischemia to 86 +/- 18 and 112 +/- 19% of the baseline in the IPC group was, respectively, significantly greater than that to 65 +/- 10 and 72 +/- 10% in the control group. Landiolol 300 microM also increased the CF and MVO(2) significantly (97 +/- 19 and 98 +/- 39%) compared to the control. IPC + landiolol 500 microM reduced the increase in LV end-diastolic pressure significantly compared to the control. IPC, landiolol (100, 300, and 500 microM), and IPC + landiolol (100, 300, and 500 microM) all decreased infarct sizes significantly to 23.5 +/- 15.2, 29.8 +/- 12.1, 30.2 +/- 13.3, 22.8 +/- 14.8, 21.6 +/- 7.8, 34.2 +/- 14.7 and 25.5 +/- 11.3% of the total left ventricular mass, respectively, compared to the control (53.3 +/- 12.5%), but there were no significant differences among these groups.

Conclusion: IPC and landiolol have cardioprotective effects on ischemia-reperfusion injury in isolated rat hearts, but pretreatment with landiolol does not enhance the cardioprotective effect of IPC.

References

Efstathiou A, Seraskeris S, Papakonstantinou C, Aidonopoulos A, Lazou A . Differential effect of preconditioning on post-ischaemic myocardial performance in the absence of substantial infarction and in extensively infarcted rat hearts. Eur J Cardiothorac Surg. 2001; 19(4):493-9. DOI: 10.1016/s1010-7940(01)00602-9. View

Sakanashi M, Sakanashi M, Sugahara K, Sakanashi M . Effects of landiolol on mechanical and metabolic changes in rat reperfused ischaemic hearts. Clin Exp Pharmacol Physiol. 2007; 34(1-2):55-60. DOI: 10.1111/j.1440-1681.2007.04543.x. View

Spear J, Prabu S, Galati D, Raza H, Anandatheerthavarada H, Avadhani N . beta1-Adrenoreceptor activation contributes to ischemia-reperfusion damage as well as playing a role in ischemic preconditioning. Am J Physiol Heart Circ Physiol. 2007; 292(5):H2459-66. DOI: 10.1152/ajpheart.00459.2006. View

Goto M, Miura T, Itoya M, Sakamoto J, Iimura O . Reduction of regional contractile function by preconditioning ischemia does not play a permissive role in the infarct size-limitation by the preconditioning. Basic Res Cardiol. 1993; 88(6):594-606. DOI: 10.1007/BF00788877. View

Saidi R, Chang J, Brooks S, Nalbantoglu I, Adsay V, Jacobs M . Ischemic preconditioning and intermittent clamping increase the tolerance of fatty liver to hepatic ischemia-reperfusion injury in the rat. Transplant Proc. 2007; 39(10):3010-4. DOI: 10.1016/j.transproceed.2007.09.044. View

Liu G, Thornton J, Van Winkle D, Stanley A, Olsson R, Downey J . Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart. Circulation. 1991; 84(1):350-6. DOI: 10.1161/01.cir.84.1.350. View

Lochner A, Genade S, Tromp E, Podzuweit T, Moolman J . Ischemic preconditioning and the beta-adrenergic signal transduction pathway. Circulation. 1999; 100(9):958-66. DOI: 10.1161/01.cir.100.9.958. View

Yellon D, Downey J . Preconditioning the myocardium: from cellular physiology to clinical cardiology. Physiol Rev. 2003; 83(4):1113-51. DOI: 10.1152/physrev.00009.2003. View

Iguchi S, Iwamura H, Nishizaki M, Hayashi A, Senokuchi K, Kobayashi K . Development of a highly cardioselective ultra short-acting beta-blocker, ONO-1101. Chem Pharm Bull (Tokyo). 1992; 40(6):1462-9. DOI: 10.1248/cpb.40.1462. View

10.

Iliodromitis E, Lazou A, Kremastinos D . Ischemic preconditioning: protection against myocardial necrosis and apoptosis. Vasc Health Risk Manag. 2007; 3(5):629-37. PMC: 2291307. View

11.

Jenkins D, Pugsley W, Yellon D . Ischaemic preconditioning in a model of global ischaemia: infarct size limitation, but no reduction of stunning. J Mol Cell Cardiol. 1995; 27(8):1623-32. DOI: 10.1016/s0022-2828(95)90590-1. View

12.

Yamazaki A, Kinoshita H, Shimogai M, Fujii K, Nakahata K, Hironaka Y . Landiolol attenuates tachycardia in response to endotracheal intubation without affecting blood pressure. Can J Anaesth. 2005; 52(3):254-7. DOI: 10.1007/BF03016059. View

13.

Takahashi Y, Takemura S, Minamiyama Y, Shibata T, Hirai H, Sasaki Y . Landiolol has cardioprotective effects against reperfusion injury in the rat heart via the PKCepsilon signaling pathway. Free Radic Res. 2007; 41(7):757-69. DOI: 10.1080/10715760701338810. View

14.

Mieno S, Horimoto H, Kishida K, Horimoto S, Sasaki S . Landiolol enhances effect of ischemic preconditioning in isolated rabbit hearts. Asian Cardiovasc Thorac Ann. 2006; 14(3):239-43. DOI: 10.1177/021849230601400315. View

15.

Rodrigo G, Samani N . Ischemic preconditioning of the whole heart confers protection on subsequently isolated ventricular myocytes. Am J Physiol Heart Circ Physiol. 2007; 294(1):H524-31. DOI: 10.1152/ajpheart.00980.2007. View

16.

Tong H, Bernstein D, Murphy E, Steenbergen C . The role of beta-adrenergic receptor signaling in cardioprotection. FASEB J. 2005; 19(8):983-5. DOI: 10.1096/fj.04-3067fje. View

17.

Mieno S, Horimoto H, Sawa Y, Watanabe F, Furuya E, Horimoto S . Activation of beta2-adrenergic receptor plays a pivotal role in generating the protective effect of ischemic preconditioning in rat hearts. Scand Cardiovasc J. 2005; 39(5):313-9. DOI: 10.1080/14017430510009104. View

18.

Wikstrom B, Ronquist G, Waldenstrom A . No further improvement of ischaemic myocardial metabolism by combining preconditioning with beta-blockade: an in vivo experimental study in the pig heart using a microdialysis technique. Acta Physiol Scand. 1997; 159(1):23-32. DOI: 10.1046/j.1365-201X.1997.558336000.x. View

19.

Yasuda T, Kamiya H, Tanaka Y, Watanabe G . Ultra-short-acting cardioselective beta-blockade attenuates postischemic cardiac dysfunction in the isolated rat heart. Eur J Cardiothorac Surg. 2001; 19(5):647-52. DOI: 10.1016/s1010-7940(01)00658-3. View

20.

Sahinkanat T, Ozkan K, Tolun F, Ciralik H, Imrek S . The protective effect of ischemic preconditioning on rat testis. Reprod Biol Endocrinol. 2007; 5:47. PMC: 2231361. DOI: 10.1186/1477-7827-5-47. View